Evidence map›Paper›PMID 33815377›Full record

ArticleFrontiers in immunology2021

Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection.

Carlos Lamsfus Calle, Rolf Fendel, Anurag Singh, Thomas L Richie, Stephen L Hoffman, Peter G Kremsner, Benjamin Mordmüller

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Proliferation of MDSCs may indicate a lowerParasite (Paris, France) · 2024
    Article
  6. Here, There, and Everywhere: Myeloid-Derived Suppressor Cells in Immunology.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Immunosuppression in Malaria: DoPathogens (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Carlos Lamsfus CalleInstitute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
Rolf FendelInstitute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
Anurag SinghDepartment of Pediatrics 1, University Children's Hospital Tübingen, Tübingen, Germany.
Thomas L RichieSanaria Inc., Rockville, MD, United States.
Stephen L HoffmanSanaria Inc., Rockville, MD, United States.
Peter G KremsnerInstitute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
Benjamin MordmüllerInstitute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
University of Tübingen · DESanaria · USUniversity Children's Hospital Tübingen · DE

Funding

Plasmodium Falciparum Whole Sporozoite Malaria VaccineR44AI055229 · NIAID · SANARIA, INC. · PI HOFFMAN, STEPHEN LEV · 2005 to 2015
$10.0M
Universal Attenuated Sporozoite Vaccine and Challenge SystemR44AI058375 · NIAID · SANARIA, INC. · PI HOFFMAN, STEPHEN LEV · 2006 to 2018
$9.9M
NIAID NIH HHS R44 AI055229NIAID NIH HHS R44 AI058375
6 · The paper itself

Abstract

Malaria can cause life-threatening complications which are often associated with inflammatory reactions. More subtle, but also contributing to the burden of disease are chronic, often subclinical infections, which result in conditions like anemia and immunologic hyporesponsiveness. Although very frequent, such infections are difficult to study in endemic regions because of interaction with concurrent infections and immune responses. In particular, knowledge about mechanisms of malaria-induced immunosuppression is scarce. We measured circulating immune cells by cytometry in healthy, malaria-naïve, adult volunteers undergoing controlled human malaria infection (CHMI) with a focus on potentially immunosuppressive cells. Infectious

Indexed as

Cell ProliferationAntimalarialsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCells, CulturedClinical Trials as TopicCoculture TechniquesHost-Pathogen InteractionsHumansLymphocyte ActivationMalaria, FalciparumMalaria VaccinesMyeloid-Derived Suppressor CellsPlasmodium falciparumSporozoitesTime FactorsAntimalarialsMalaria Vaccinescontrolled human malaria infectionimmunosuppressionmalaria vaccinemyeloid-derived suppressor cellsPfSPZ-CVacPfSPZ vaccinePlasmodium falciparumregulatory T cell

Identifiers

PMID33815377
PMCPMC8017236
OpenAlexW3138353028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.